Step 1: Classify the options into bone-active categories. Drugs that reduce bone breakdown are anti-resorptive; drugs that stimulate formation are anabolic.
Step 2: Risedronate belongs to the nitrogen-containing bisphosphonate group. It is taken up by osteoclasts and disrupts their function, so they can no longer erode the bone surface, directly lowering resorption.
Step 3: Teriparatide, given as intermittent PTH, falls in the anabolic group; it improves skeletal microarchitecture by adding bone, not by suppressing osteoclasts, so it does not fit "decreases bone resorption."
Step 4: Cortisone promotes bone loss and is a cause of secondary osteoporosis, while cimetidine is unrelated to bone metabolism. The only true anti-resorptive listed is risedronate.
\[\boxed{\text{Risedronate}}\]